Incruse Ellipta is prescription medicine used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It contains the active ingredient umeclidinium. Umeclidinium belongs to a group of medicines called bronchodilators. It helps open the airways and makes it easier for air to get in and out of the lungs.
Incruse Ellipta comes in the form of a light grey and light green plastic inhaler containing a foil blister strip, and each blister on the strip contains a white powder mix of the medicine. To use it, you breathe it into your lungs through your mouth using the inhaler. It is not intended to provide immediate relief, but you should expect to breathe easier over time with regular use.
Uses and Dosage
Incruse Ellipta halation powder is taken by mouth using an inhaler, once daily as directed by your doctor. Do not open the cover of the inhaler until you are ready to use it, since doing so prepares a dose of the medication. In case you open and close the inhaler without inhaling, the dose will be lost. Therefore, to avoid wasting a dose, inhale the medication immediately after opening the cover and do not close it until after inhaling. While inhaling, it is possible to taste or feel the drug, but do not exhale into the inhaler.
Common Side Effects of Incruse Ellipta (Umeclidinium Bromide):
- Abdominal discomfort
- Dark areas of the skin
- Stuffy and runny nose
- Throat irritation
Serious Side Effects of Incruse Ellipta (Umeclidinium Bromide)
- Chest pain
- Eye pain
- Irregular heartbeat
- Painful or difficult urination
- Signs of infection (fever, persistent sore throat, chills)
- Vision changes or blurred vision
Form and Strength
Incruse Ellipta (Umeclidinium Bromide) is available in the following forms and strengths:
Incruse Ellipta: Powder Inhalation
- 62.5 mcg
- Before using umeclidinium, inform your healthcare provider or pharmacist about any allergies you may have. It contains inactive ingredients, such as milk proteins, which can cause allergic reactions or other adverse effects. For additional information, speak with your pharmacist.
- Incruse Ellipta is not a rescue medication, and it will not work fast enough to treat a bronchospasm attack. Patients should use a fast-acting inhalation medicine for an attack instead.
- Umeclidinium should only be used when clearly needed, and the risks and benefits should be discussed with a doctor.
- Before using umeclidinium, it is important to inform your doctor or pharmacist about your medical history, especially if you have a personal or family history of glaucoma (angle-closure type) or difficulty urinating, such as due to an enlarged prostate.
Frequently Asked Questions (FAQ)
How do I use Incruse Ellipta inhaler?
To use Incruse Ellipta, you breathe it into your lungs through your mouth using the inhaler. Follow the instructions provided by your healthcare provider.
How long does it take for Incruse Ellipta to work?
Incruse Ellipta is not intended to provide immediate relief, but with regular use, you should expect to breathe easier over time.
Can I take Incruse Ellipta if I am pregnant or breastfeeding?
Talk to your doctor before taking Incruse Ellipta if you are pregnant, planning to become pregnant, or breastfeeding.
Can I use Incruse Ellipta with other medicines?
Tell your doctor about all the medicines you are taking, including over-the-counter medicines and supplements, before using Incruse Ellipta.
How often should I use Incruse Ellipta?
Follow the instructions provided by your healthcare provider. Typically, Incruse Ellipta is used once daily.
Can I stop using Incruse Ellipta if I feel better?
Do not stop using Incruse Ellipta as prescribed, even if your symptoms improve. Stopping the medicine without your doctor’s guidance may worsen your condition.